Tern Plc comments on significant rise in the share price of Wyld Networks AB

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has noted the recent rise in the Company’s share price. The Board also notes today’s significant rise in the share price of Wyld Networks AB. Wyld Networks has published a press release today in relation to the signing of an agreement with SpaceX to discuss potential areas of collaboration.

Wyld Networks is a portfolio company of Tern’s in which Tern currently owns approximately 27%.

Extracted from a translation of the Wyld Networks press release:

“Space X offers satellite connectivity for broadband through Starlink and connectivity for IoT through Swarm. Wyld and SpaceX will explore potential areas of collaboration to collect data from IoT sensors in remote locations.

Satellite connectivity can help bridge the digital divide and increase the reach and resilience of connections for IoT devices. This is particularly the case for the 85% of the Earth’s surface that has no cellular coverage.

Both SpaceX and Wyld Networks operate on low-bandwidth satellite connectivity using satellites orbiting in low orbit. These satellites cover every point on Earth, enabling IoT devices to operate and deliver data at an affordable price, anywhere on Earth.

SpaceX and Wyld will initially explore the potential of offering remote connectivity in North, Central and South America.

Wyld Networks’ IoT engineering team is a leader in delivering satellite IoT connectivity solutions. Their innovative technology leads to exceptional performance with satellites orbiting the Earth in low Earth orbit.

“We are excited to explore possible areas with SpaceX where our technology can enable additional connectivity and access to data from sensors and devices in remote locations,” said Alastair Williamson, CEO Wyld Networks. “With Wyld Connect available to deliver data from IoT devices anywhere on Earth, this is a great opportunity to partner with the world’s most important satellite companies.””

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Pharma faces a strategic turning point in AI adoption

AI in pharma is moving from operational support to strategic driver as companies prioritise messaging that delivers measurable prescriber impact.

Tern Plc updates position in Talking Medicines with new convertible loan notes

Tern Plc has received about £230,000 in new unsecured convertible loan notes from Talking Medicines after cancelling around £180,000 of short term loans provided over 2024 and 2025.

The real problem holding back connected vehicle programmes

Vehicle identity is fast becoming a core infrastructure challenge, and a new bottleneck for OEMs aiming to scale software-defined platforms.

Talking Medicines is building the AI layer beneath pharma marketing

Talking Medicines is shifting pharma marketing from content creation to data control, building the layer AI tools rely on to deliver credible, measurable clinical messaging.

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature.

Turning employee sentiment into hard operational data

Workforce wellbeing is becoming a source of operational data, and the companies acting early are already reducing risk.

Search

Search